开立医疗
(300633)
| 流通市值：156.99亿 | | | 总市值：156.99亿 |
| 流通股本：4.33亿 | | | 总股本：4.33亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,554,911,156.3 | 1,541,568,915.19 | 1,898,798,163.94 | 1,774,621,016.57 |
| 应收票据及应收账款 | 161,476,042.33 | 236,286,693.18 | 176,834,318.23 | 174,224,263.72 |
| 其中：应收票据 | 805,516 | 6,230,691.9 | 6,691,281.48 | - |
| 应收账款 | 160,670,526.33 | 230,056,001.28 | 170,143,036.75 | 174,224,263.72 |
| 预付款项 | 54,239,743.42 | 74,131,873.13 | 65,565,101.71 | 55,331,152.37 |
| 其他应收款合计 | 15,749,613.14 | 13,593,816.28 | 13,255,050.55 | 11,570,420.03 |
| 存货 | 776,308,431.54 | 669,810,625.22 | 619,198,889.75 | 531,476,404.12 |
| 一年内到期的非流动资产 | 5,735,625 | 6,141,750 | 10,334,625 | 7,158,250 |
| 其他流动资产 | 27,909,060.54 | 29,085,412.32 | 24,877,273.15 | 19,624,488.71 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,890,010,108.38 | 2,956,433,854.09 | 2,873,808,422.33 | 2,625,395,995.52 |
| 非流动资产: | | | | |
| 长期应收款 | 10,771,567.27 | 12,215,037.7 | 9,680,896.08 | 14,458,930.24 |
| 其他权益工具投资 | 8,202,777 | 8,202,777 | 8,202,777 | 8,202,777 |
| 固定资产 | 422,714,260.53 | 424,594,034.72 | 420,817,990.4 | 419,545,760.99 |
| 在建工程 | 348,908,744.32 | 293,394,624.59 | 252,248,017.67 | 254,203,561.52 |
| 使用权资产 | 49,918,156.36 | 48,165,799.61 | 44,096,960.82 | 46,145,493.51 |
| 无形资产 | 157,417,459.07 | 161,281,705.23 | 164,622,632.96 | 164,854,790.33 |
| 商誉 | 164,104,141.71 | 166,950,249.99 | 165,899,049.19 | 165,899,049.19 |
| 长期待摊费用 | 32,210,557.23 | 32,140,627.31 | 35,572,250.25 | 17,929,077.74 |
| 递延所得税资产 | 36,384,635.2 | 36,216,901.13 | 28,761,877.82 | 30,601,841.92 |
| 其他非流动资产 | 35,495,638.53 | 51,330,813.08 | 39,943,415.6 | 24,179,816.87 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,266,127,937.22 | 1,234,492,570.36 | 1,169,845,867.79 | 1,146,021,099.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,156,138,045.6 | 4,190,926,424.45 | 4,043,654,290.12 | 3,771,417,094.83 |
| 流动负债: | | | | |
| 短期借款 | 310,405,254.91 | 311,516,168.41 | 249,990,088.94 | 23,628,320.07 |
| 交易性金融负债 | - | 14,816.54 | 2,006,568.71 | 1,565,542.46 |
| 应付票据及应付账款 | 291,097,414.35 | 259,194,278.17 | 226,897,470.24 | 186,145,110.95 |
| 应付账款 | 291,097,414.35 | 259,194,278.17 | 226,897,470.24 | 186,145,110.95 |
| 合同负债 | 63,640,899.76 | 48,092,701.72 | 46,346,122.68 | 44,592,473.23 |
| 应付职工薪酬 | 147,212,039.53 | 116,946,819.51 | 99,296,976.82 | 170,492,881.54 |
| 应交税费 | 23,162,714.69 | 44,424,148.31 | 24,204,949.56 | 38,891,638.12 |
| 其他应付款合计 | 81,864,061.81 | 97,180,093.97 | 67,666,041.92 | 82,900,707.78 |
| 一年内到期的非流动负债 | 14,798,793.66 | 14,798,793.66 | 13,594,159.69 | 14,808,514.68 |
| 其他流动负债 | 2,999,609.43 | 1,562,601.31 | 1,631,655.97 | 5,599,709.45 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 935,180,788.14 | 893,730,421.6 | 731,634,034.53 | 568,624,898.28 |
| 非流动负债: | | | | |
| 长期借款 | 40,000,000 | 40,000,000 | - | - |
| 租赁负债 | 38,923,580.76 | 35,762,078.9 | 32,419,721.28 | 34,007,440.07 |
| 递延收益 | 21,905,733.91 | 23,082,651.07 | 23,252,141.59 | 22,831,105.2 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 100,829,314.67 | 98,844,729.97 | 55,671,862.87 | 56,838,545.27 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,036,010,102.81 | 992,575,151.57 | 787,305,897.4 | 625,463,443.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 432,712,405 | 432,712,405 | 432,550,255 | 430,652,785 |
| 资本公积 | 1,177,605,011.44 | 1,168,699,337.32 | 1,157,483,836.45 | 1,118,989,432.68 |
| 减:库存股 | 120,007,227.23 | 91,842,579.23 | 91,842,579.23 | 59,992,347.23 |
| 其他综合收益 | 26,113,436.96 | 23,490,242.28 | 25,444,014.12 | 23,781,742.08 |
| 盈余公积 | 203,824,055.73 | 203,824,055.73 | 203,824,055.73 | 203,824,055.73 |
| 未分配利润 | 1,399,880,260.89 | 1,461,467,811.78 | 1,528,888,810.65 | 1,428,697,983.02 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,120,127,942.79 | 3,198,351,272.88 | 3,256,348,392.72 | 3,145,953,651.28 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,120,127,942.79 | 3,198,351,272.88 | 3,256,348,392.72 | 3,145,953,651.28 |
| 负债和股东权益合计 | 4,156,138,045.6 | 4,190,926,424.45 | 4,043,654,290.12 | 3,771,417,094.83 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-27 | 2024-04-12 |
| 审计意见(境内) | | | | 标准无保留意见 |